GemPharmatech Statistics

Total Valuation

GemPharmatech has a market cap or net worth of CNY 4.73 billion. The enterprise value is 3.75 billion.

Market Cap	4.73B
Enterprise Value	3.75B

Important Dates

The last earnings date was Saturday, April 26, 2025.

Earnings Date	Apr 26, 2025
Ex-Dividend Date	Nov 4, 2024

Share Statistics

GemPharmatech has 407.41 million shares outstanding. The number of shares has decreased by -1.73% in one year.

Current Share Class	407.41M
Shares Outstanding	407.41M
Shares Change (YoY)	-1.73%
Shares Change (QoQ)	+7.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	20.77%
Float	156.52M

Valuation Ratios

The trailing PE ratio is 42.96 and the forward PE ratio is 29.00.

PE Ratio	42.96
Forward PE	29.00
PS Ratio	6.75
PB Ratio	2.19
P/TBV Ratio	2.24
P/FCF Ratio	631.97
P/OCF Ratio	40.67
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.22, with an EV/FCF ratio of 501.78.

EV / Earnings	34.01
EV / Sales	5.36
EV / EBITDA	20.22
EV / EBIT	39.45
EV / FCF	501.78

Financial Position

The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.10.

Current Ratio	4.32
Quick Ratio	3.99
Debt / Equity	0.10
Debt / EBITDA	1.16
Debt / FCF	28.86
Interest Coverage	21.62

Financial Efficiency

Return on equity (ROE) is 5.14% and return on invested capital (ROIC) is 2.56%.

Return on Equity (ROE)	5.14%
Return on Assets (ROA)	2.28%
Return on Invested Capital (ROIC)	2.56%
Return on Capital Employed (ROCE)	4.22%
Revenue Per Employee	443,983
Profits Per Employee	69,912
Employee Count	1,578
Asset Turnover	0.27
Inventory Turnover	4.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.40% in the last 52 weeks. The beta is 0.46, so GemPharmatech's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+1.40%
50-Day Moving Average	12.57
200-Day Moving Average	12.90
Relative Strength Index (RSI)	42.17
Average Volume (20 Days)	4,491,462

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GemPharmatech had revenue of CNY 700.61 million and earned 110.32 million in profits. Earnings per share was 0.27.

Revenue	700.61M
Gross Profit	429.57M
Operating Income	95.11M
Pretax Income	121.68M
Net Income	110.32M
EBITDA	174.60M
EBIT	95.11M
Earnings Per Share (EPS)	0.27

Full Income Statement

Balance Sheet

The company has 1.19 billion in cash and 215.84 million in debt, giving a net cash position of 973.59 million or 2.39 per share.

Cash & Cash Equivalents	1.19B
Total Debt	215.84M
Net Cash	973.59M
Net Cash Per Share	2.39
Equity (Book Value)	2.16B
Book Value Per Share	5.27
Working Capital	1.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 116.19 million and capital expenditures -108.71 million, giving a free cash flow of 7.48 million.

Operating Cash Flow	116.19M
Capital Expenditures	-108.71M
Free Cash Flow	7.48M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 61.31%, with operating and profit margins of 13.58% and 15.75%.

Gross Margin	61.31%
Operating Margin	13.58%
Pretax Margin	17.37%
Profit Margin	15.75%
EBITDA Margin	24.92%
EBIT Margin	13.58%
FCF Margin	1.07%

Dividends & Yields

This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 1.21%.

Dividend Per Share	0.14
Dividend Yield	1.21%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	72.76%
Buyback Yield	1.73%
Shareholder Yield	2.94%
Earnings Yield	2.33%
FCF Yield	0.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GemPharmatech has an Altman Z-Score of 7.57.

Altman Z-Score	7.57
Piotroski F-Score	n/a